Subscribe
gavel-istock-508411976_andreypopov
AndreyPopov / iStockphoto.com
5 December 2018Americas

GE Healthcare files patent lawsuit against Bio-Rad

American conglomerate GE Healthcare (GE) last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
GE life sciences expansion costs $1.06 billion
13 January 2014   General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.
Americas
GE Healthcare partners with Vanderbilt University to create AI apps
17 January 2019   US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
Big Pharma
GE to sell biopharma unit to Danaher for $21.4 billion
28 February 2019   General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
GE life sciences expansion costs $1.06 billion
13 January 2014   General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.
Americas
GE Healthcare partners with Vanderbilt University to create AI apps
17 January 2019   US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
Big Pharma
GE to sell biopharma unit to Danaher for $21.4 billion
28 February 2019   General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.

More on this story

Americas
GE life sciences expansion costs $1.06 billion
13 January 2014   General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.
Americas
GE Healthcare partners with Vanderbilt University to create AI apps
17 January 2019   US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
Big Pharma
GE to sell biopharma unit to Danaher for $21.4 billion
28 February 2019   General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent